NYSEARCA:BBC

Virtus LifeSci Biotech Clinical Trials ETF (BBC) Price, Holdings, & News

$24.83

+0.21 (+0.85%)

(As of 06/2/2023 ET)

Compare

Today's Range: $24.81
▼
$24.83
50-Day Range: $21.24
▼
$25.38
52-Week Range: $17.77
▼
$29.08

Volume: 1,873 shs
Average Volume: 2,340 shs
Market Capitalization: $12.41 million

Assets Under Management: $12.29 million
Dividend Yield: 0.00%
Net Expense Ratio: 0.79%

Profile Chart Headlines Holdings

About Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC)

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.

Receive BBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter.

BBC ETF News Headlines

May 8, 2023 | finance.yahoo.com

4 Best-Performing ETF Areas of Last Week

April 2, 2023 | finance.yahoo.com

Biotech Stocks Languish After Dismal Quarter of Clinical Results

June 3, 2023 | Vantage Point (Ad)

We Called (ARWR) In Advance, Which Stocks Are Next?

Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.

March 29, 2023 | bbc.com

Gwyneth Paltrow ski crash trial: Who's who

February 23, 2023 | cbsnews.com

Clinical trial helping stroke victims regain functions

January 25, 2023 | bizjournals.com

Rockville biotech RegenxBio launches clinical trial in muscular dystrophy

January 9, 2023 | benzinga.com

Trevena Enrolls First Subject in TRV045 Proof-of-Concept Trial Evaluating S1PR Mechanism of Action and Target Engagement

September 27, 2022 | uk.finance.yahoo.com

5 Best Areas of Q3 of 2022 & Their Top ETFs

June 3, 2023 | Vantage Point (Ad)

Instantly Find Hidden Trade Opportunities

There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market.

July 1, 2022 | msn.com

Best Performing ETFs For June 2022

See More Headlines

BBC Price History

30 days | 90 days | 365 days | Advanced Chart

Fund Details

Issuer: Virtus
Fund Name: Virtus LifeSci Biotech Clinical Trials ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NYSEARCA
Current Symbol: NYSEARCA:BBC
Inception Date: 12/16/2014
Fund Manager: Matthew B. Brown, Seth Kadushin
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: LifeSci Biotechnology Clinical Trials Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: North America
Number of Holdings: 125

Fund Statistics

Assets Under Management: $12.29 million
Average Daily Volume: $2,946.40
Discount/Premium: 0.03%

Administrator, Advisor and Custodian

Administrator: Virtus ETF Solutions, LLC
Advisor: Virtus ETF Advisers LLC
Custodian: The Bank of New York Mellon Corporation
Distributor: ETF Distributors LLC
Transfer Agent: The Bank of New York Mellon Corporation
Trustee: N/A
Lead Market Maker: Virtu Financial

Miscellaneous

Outstanding Shares: 500,000
Beta: 1.08
Creation Unit: 50,000
Creation Fee: $500.00

Virtus LifeSci Biotech Clinical Trials ETF Expenses

Type	BBC	Health Care ETFs	Equity ETFs	NYSEARCA ETFs	All ETFs
Management Fee	0.79%	0.54%	0.52%	0.50%	0.49%
Other Expenses	0.00%	0.41%	0.48%	0.64%	0.51%
Total Expense	0.79%	0.69%	0.67%	0.74%	0.66%
Fee Waiver	0.00%	-0.39%	-0.49%	-0.69%	-0.52%
Net Expense	0.79%	0.60%	0.58%	0.57%	0.55%

Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings & Exposure

Top 10 BBC Holdings

BBC Sector Exposure

BBC Industry Exposure

Full Holdings Details

Similar ETFs

BBC ETF - Frequently Asked Questions

How have BBC shares performed in 2023?: Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $24.99 on January 1st, 2023. Since then, BBC stock has decreased by 0.6% and is now trading at $24.8282.
View the best growth stocks for 2023 here.
What does BBC invest in?: Virtus LifeSci Biotech Clinical Trials ETF is a equity fund issued by Virtus. BBC focuses on health care investments and follows the LifeSci Biotechnology Clinical Trials Index. The fund's investments total to approximately $12.29 million assets under management.
What stocks does Virtus LifeSci Biotech Clinical Trials ETF hold?: BBC invests in 125 holdings. Some of the stocks in their portfolio include Madrigal Pharmaceuticals (MDGL), TG Therapeutics (TGTX), Reata Pharmaceuticals (RETA), Protagonist Therapeutics (PTGX), Morphic (MORF), Summit Therapeutics (SMMT), Prometheus Biosciences (RXDX), IVERIC bio (ISEE), Arcturus Therapeutics (ARCT) and Merus (MRUS).
What is the management fee for Virtus LifeSci Biotech Clinical Trials ETF?: Virtus LifeSci Biotech Clinical Trials ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for BBC is 0.79%.

What other stocks do shareholders of Virtus LifeSci Biotech Clinical Trials ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Virtus LifeSci Biotech Clinical Trials ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Simon Property Group (SPG), Cisco Systems (CSCO), Micron Technology (MU), Alibaba Group (BABA) and Johnson & Johnson (JNJ).
What is Virtus LifeSci Biotech Clinical Trials ETF's stock symbol?: Virtus LifeSci Biotech Clinical Trials ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BBC."
How do I buy shares of Virtus LifeSci Biotech Clinical Trials ETF?: Shares of BBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Virtus LifeSci Biotech Clinical Trials ETF's stock price today?: One share of BBC stock can currently be purchased for approximately $24.83.
How much money does Virtus LifeSci Biotech Clinical Trials ETF make?: Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) has a market capitalization of $12.41 million.

This page (NYSEARCA:BBC) was last updated on 6/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial